Gilead Appoints Cindy Perettie Executive Vice President of Kite
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Cindy Perettie will join the company as Executive Vice President of Kite, a Gilead Company, overseeing the cell therapy business, and will become a member of Gilead’s senior leadership team, effective May 30.
- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Cindy Perettie will join the company as Executive Vice President of Kite, a Gilead Company, overseeing the cell therapy business, and will become a member of Gilead’s senior leadership team, effective May 30.
- View the full release here: https://www.businesswire.com/news/home/20230516005214/en/
Gilead Appoints Cindy Perettie Executive Vice President of Kite (Photo: Business Wire)
Ms. Perettie brings with her extensive experience in oncology and a commitment to improving patient care. - “Cindy has more than 20 years’ experience in scientific and commercial leadership in oncology and has dedicated her career to improving the care of cancer,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead.
- I believe with the continued focus and commitment of the Kite team we will be able to reach many more cancer patients around the world.”